Restore Robotics Pursues FDA Approval for Robotic Surgery Tools

Restore Robotics Pursues FDA Approval for Robotic Surgery Tools
Restore Robotics, renowned for its advancements in surgical robotics, is excited to share that its subsidiary, Iconocare Health, recently submitted a 510(k) application to the U.S. Food and Drug Administration (FDA). This application is a pivotal move toward gaining clearance for the remanufacturing of the Da Vinci Xi® 8mm Monopolar Curved Scissors. This initiative is part of Restore Robotics' ongoing mission to provide hospitals with affordable and high-quality remanufactured robotic instruments.
Significant Cost Savings for Hospitals
With the focus on delivering efficient surgical solutions, Restore Robotics aims to reduce hospital expenses significantly. By opting for remanufactured instruments, health facilities will benefit from substantial cost savings compared to purchasing new devices. This enables hospitals to allocate their budgets more efficiently, making cutting-edge robotic surgery accessible to more patients in need.
Environmental Sustainability Initiatives
In addition to cost savings, Restore Robotics is proud to implement sustainability initiatives within the medical community. The company has launched a Da Vinci Xi® recycling program, which involves collecting expired surgical instruments from hospitals. This program, conducted at Restore Robotics' facility, seeks to minimize medical waste while ensuring that surgical instruments have an extended lifecycle through remanufacturing.
CEO's Vision for the Future
"With this FDA submission, we are committed to providing hospitals with solutions that prioritize both cost-efficiency and quality," expressed Clif Parker, CEO of Restore Robotics. "Our partners can rely on our remanufactured Da Vinci Xi® 8mm Monopolar Curved Scissors, allowing for better resource management and surgical care delivery." This dedication to high standards blends seamlessly with Restore Robotics' goal of enhancing healthcare practices.
Partnerships for Broader Access
Restore Robotics has formed a marketing and distribution partnership with Encore Medical Device Repair to efficiently deliver remanufactured surgical instruments across the U.S. This collaboration enhances the availability of affordable, high-standard robotic instruments for use on the Da Vinci® platform. Rick Ferreira, Chairman of Encore, articulated that this partnership reflects a shared mission to improve patient care and surgical outcomes through innovative solutions.
This Partnership’s Impact on Healthcare
“Restore Robotics' commitment to ensuring that hospitals can access remanufactured robotic instruments showcases the company’s focus on responsible asset management for both the benefit of patients and providers,” Ferreira added. The synergy between these two forward-thinking companies is poised to make a real difference in the landscape of robotic surgery.
About Restore Robotics
Based in Panama City Beach, Florida, Restore Robotics is pioneering the surgical robotics industry, continuously seeking ways to enhance the performance and sustainability of essential surgical systems. The company’s operations in Henderson, Nevada, are pivotal in promoting environmentally friendly practices within healthcare.
About Encore Medical Device Repair
Encore Medical Device Repair is a preeminent provider of medical device repair services dedicated to prolonging the lifespan of critical medical instruments. By teaming up with Restore Robotics, Encore not only provides hospitals with reliable instruments but does so in a cost-effective and sustainable manner.
Contact and Further Information
To learn more about Restore Robotics and its initiatives, please visit the official website or reach out for further inquiries about their exciting services and products. For direct contact, Clif Parker, CEO of Restore Robotics, can be reached by phone at 678-619-0011. Restore Robotics operates independently and is not associated with Intuitive Surgical®, Inc. or its affiliated brands.
Frequently Asked Questions
What is the purpose of Restore Robotics' 510(k) application?
The application seeks FDA clearance to remanufacture the Da Vinci Xi® 8mm Monopolar Curved Scissors, aiming to provide high-quality and cost-effective surgical tools to hospitals.
How does remanufacturing benefit hospitals?
Hospitals benefit from remanufactured instruments by saving significantly compared to new devices, which allows for better budget management and resource allocation.
What is the Da Vinci Xi® recycling program?
The recycling program collects expired surgical instruments to remanufacture them, reducing medical waste and promoting sustainability in healthcare environments.
Who partners with Restore Robotics for distribution?
Restore Robotics partners with Encore Medical Device Repair to facilitate the delivery of remanufactured instruments across the U.S., enhancing access to surgical tools.
What is Restore Robotics' commitment to sustainability?
The company aims to extend the lifecycle of robotic instruments to lessen their environmental impact and reduce waste generated by the healthcare sector.
About The Author
Contact Kelly Martin privately here. Or send an email with ATTN: Kelly Martin as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.